Market Cap:	₹78.7 Cr	Book Value:	₹50.8
Lot Size:	100 shares	52 Week High:	₹350
52 Week Low:	₹163	EPS:	₹15.6
Demat Account:	Required	PB:	4.25
Face Value:	₹10	Debt To Equity:	0.06
No Of Shares:	36,42,000	Web Site Url:

Company Overview

Merind Limited, founded in 1958, is a legacy pharmaceutical and APIs (Active Pharmaceutical Ingredients) company headquartered in Mumbai. Now a privately held entity after delisting in 2005 (via amalgamation), Merind has a strong track record in key pharma sectors, consistently posting robust profit margins and maintaining a stable balance sheet. The company stands out for its experience in formulation and generics manufacturing, lean operations, and focus on capital stewardship—making it a unique long-term value play in India’s pharma ecosystem.

Board of Directors

Name	Designation
Huzaifa Habil Khorakiwala	Director
Zahabiya Habil Khorakiwala	Director
Stephen Sabbas D’souza	Director

 

Company Incorporation Details

Attribute	Details
Company Name	Merind Limited
CIN	U24239MH1958PLC011204
Date of Incorporation	4 November 1958
Registered Office	Readymoney Terrace, 2nd Floor, Room 5, 167 Dr. Annie Besant Road, Mumbai – 400018, Maharashtra
Face Value	₹10
ISIN	INE215A01016
Lot Size	100 shares
Demat Account	Mandatory

Shareholding Pattern (FY2025)

Category	% Holding
Promoter (Dartmour Holdings Pvt Ltd)	96.06
Public/Other Shareholders	3.94

Sector

• Industry: Pharmaceuticals
• Segment: APIs, Formulations, Heritage Generics

Why Choose Arms Securities?

Trade Merind Limited unlisted shares with confidence—benefiting from transparent pricing, regulatory safety, and true end-to-end support powered by Arms Securities.